- Report
- August 2025
- 185 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 181 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 195 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 182 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 180 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 180 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 188 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- May 2025
- 182 Pages
Global
From €3977EUR$4,500USD£3,450GBP
- Report
- August 2025
- 186 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 189 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 193 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- August 2025
- 180 Pages
Global
From €3133EUR$3,545USD£2,718GBP
€3481EUR$3,939USD£3,020GBP
- Report
- May 2025
- 150 Pages
Global
From €2892EUR$3,273USD£2,509GBP
€3402EUR$3,850USD£2,952GBP
- Report
- May 2025
- 120 Pages
Global
From €4197EUR$4,750USD£3,642GBP
- Report
- May 2025
- 150 Pages
Global
From €4197EUR$4,750USD£3,642GBP
- Report
- July 2025
- 150 Pages
Global
From €2967EUR$3,358USD£2,574GBP
€3491EUR$3,950USD£3,028GBP
- Report
- July 2025
- 197 Pages
Global
From €4374EUR$4,950USD£3,795GBP
- Report
- May 2025
- 199 Pages
Global
From €4374EUR$4,950USD£3,795GBP
- Report
- May 2025
- 110 Pages
Global
From €2607EUR$2,950USD£2,262GBP
- Report
- March 2025
- 111 Pages
Global
From €2607EUR$2,950USD£2,262GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more